Cervantes, FC; Mizuno, T; Dong, M; Tang, P; Arbough, T; Vinks, AA; Kaplan, JM; Girdwood, SC T.
Ceftriaxone Pharmacokinetics and Pharmacodynamics in 2 Pediatric Patients on Extracorporeal Membrane Oxygenation Therapy.
Therapeutic Drug Monitoring.
2023;
45:832-836.
Stanski, NL; Basu, RK; Cvijanovich, NZ; Fitzgerald, JC; Bigham, MT; Jain, PN; Schwarz, AJ; Lutfi, R; Thomas, NJ; Baines, T; et al.
External validation of the modified sepsis renal angina index for prediction of severe acute kidney injury in children with septic shock.
Critical Care (UK).
2023;
27:463.
Bodilly, L; Williamson, L; Lahni, P; Alder, MN; Haslam, DB; Kaplan, JM.
Obesity Alters cytokine signaling and gut microbiome in septic mice.
Innate Immunity.
2023;
29:161-170.
Pavia, K; Hambrick, HR; Paice, K; Tang, P; Punt, N; Kaplan, J; Goldstein, SL; Vinks, AA; Mizuno, T; Tang Girdwood, S.
Cefepime pharmacokinetics in critically ill children and young adults undergoing continuous kidney replacement therapy.
Journal of Antimicrobial Chemotherapy.
2023;
78:2140-2147.
Tang Girdwood, S; Tang, P; Fenchel, M; Dong, M; Stoneman, E; Jones, R; Ostermeier, A; Curry, C; Forton, M; Hail, T; et al.
Pharmacokinetic parameters over time during sepsis and the association of target attainment and outcomes in critically ill children and young adults receiving ceftriaxone.
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy.
2023;
43:609-621.
Davis, X; Williamson, L; Stuck, J; Howell, K; Lahni, P; Piraino, G; Wolfe, V; Mukherjee, R; Sanchez-Gurmaches, J; Zingarelli, B; et al.
SEX-DEPENDENT EFFECTS OF ADIPOCYTE STAT3 INHIBITION ON THE INFLAMMATORY RESPONSE DURING SEVERE SEPSIS.
Shock.
2023;
59:779-790.
Bodilly, L; Williamson, L; Howell, K; Alder, MN; Kaplan, JM.
OBESE MICE WITH PNEUMONIA HAVE HYPERLEPTINEMIA AND INCREASED PULMONARY SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 3 ACTIVATION.
Shock.
2023;
59:409-416.
Girdwood, ST; Hasson, D; Caldwell, JT; Slagle, C; Dong, S; Fei, L; Tang, P; Vinks, AA; Kaplan, J; Goldstein, SL.
Relationship between piperacillin concentrations, clinical factors and piperacillin/tazobactam-associated acute kidney injury.
Journal of Antimicrobial Chemotherapy.
2023;
78:478-487.
Pavia, K; Girdwood, ST; Paice, K; Jones, R; Curry, C; Stoneman, E; Yunger, T; Gamel, N; Gibson, A; Dong, M; et al.
610: RENAL IMPAIRMENT IS ASSOCIATED WITH HIGH CEFEPIME CONCENTRATIONS IN CRITICALLY ILL CHILDREN.
Critical Care Medicine.
2023;
51:294.
Paice, K; Girdwood, ST; Pavia, K; Mizuno, T; Tang, P; Curry, C; Gibson, A; Jones, R; Stoneman, E; Yunger, T; et al.
38: CRITICALLY ILL CHILDREN WITH SEVERE SEPSIS OFTEN HAVE SUB-TARGET MEROPENEM LEVELS EARLY IN THERAPY.
Critical Care Medicine.
2023;
51:19.